Condition: Mesothelioma · Non Small Cell Lung Cancer · Malignant Peripheral Nerve Sheath Tumors · Sponsor: Bristol-Myers Squibb
This is a Phase 1, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with advanced, unresectable or metastatic solid tumor malignancy with homozygous deletion of the MTAP gene.
This description comes directly from the study's public registry record.
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com · 855-907-3286 · Clinical.Trials@bms.com
First line of the email MUST contain the NCT# and Site #.
Always discuss trial participation with your own doctor first.
| Mayo Clinic | Phoenix, Arizona, United States | Recruiting |
| Sarah Cannon Research Institute (SCRI) - HealthONE Location | Denver, Colorado, United States | Recruiting |
| Rocky Mountain Cancer Centers, LLP - Oncology | Lone Tree, Colorado, United States | Recruiting |
| Mayo Clinic | Jacksonville, Florida, United States | Recruiting |
| Sarah Cannon Research Institute at Florida Cancer Specialists | Orlando, Florida, United States | Recruiting |
| Local Institution - 124 | Chicago, Illinois, United States | Withdrawn |
| Dana-Farber Cancer Institute | Brookline, Massachusetts, United States | Recruiting |
| Cancer and Hematology Centers of Western Michigan | Norton Shores, Michigan, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Rutgers Cancer Institute of New Jersey | New Brunswick, New Jersey, United States | Recruiting |
| Local Institution - 129 | Mineola, New York, United States | Not Yet Recruiting |
| David H Koch, Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05245500